Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L ...

Efti plus Keytruda and chemo achieved a 61% response rate in first-line advanced non-squamous non–small cell lung cancer, ...

Lantern Pharma Inc. ( NASDAQ: LTRN) Q1 2025 Earnings Conference Call May 15, 2025 9:00 AM ET Panna Sharma - President & CEO David Margrave - CFO ...

Chemistry professor Chris Chang’s lab studies the chemical biology of the elements, specifically examining the roles that ...

Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for neurodegenerative ...

Auxin is the first plant hormone—or "phytohormone"—ever identified, with its discovery dating to the late 19th and early 20th ...

Collaboration combines Novo Nordisk’s scientific leadership in obesity and cardiometabolic diseases with Septerna’s expertise ...

After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

When a molecule absorbs light, it undergoes a whirlwind of quantum-mechanical transformations. Electrons jump between energy ...

Scientists report that they have learned how certain combinations of rearranged genes can promote the progression of a rare ...

Scientists have discovered how iron in lysosomes can induce ferroptosis, offering a new route to target treatment-resistant ...